USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALACIA
USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALACIA The present invention relates to the use of agomelatine, or N-[2-(7-methoxy- l-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of periventricular leukomalacia.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
27.06.2008
|
Online Access | Get full text |
Cover
Loading…
Summary: | USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF PERIVENTRICULAR LEUKOMALACIA The present invention relates to the use of agomelatine, or N-[2-(7-methoxy- l-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of periventricular leukomalacia. |
---|---|
Bibliography: | Application Number: SG20070180367 |